Last reviewed · How we verify
NCT03511092: LMET2IMPROVE
The Effects of Leucine Metabolites in Performance, Body Composition and Biochemical Markers of Muscle Damage
NA trial testing HMB-FA in Resistance Training in 53 participants. Completed in 28 October 2017.
28 October 2017
Quick facts
| Lead sponsor | Faculdade de Motricidade Humana |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | basic science |
| Enrollment | 53 |
| Start date | 29 May 2017 |
| Primary completion | 28 October 2017 |
| Estimated completion | 28 October 2017 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- HMB-FA
- HMB-Ca
- alfa-HICA
- Placebo comparator
Conditions studied
- Resistance Training — all drugs for Resistance Training →
Sponsor
Faculdade de Motricidade Humana
Who can join
Adults 18 to 45, male only, with Resistance Training. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aimed to conduct a double-blind randomized pragmatic trial to evaluate the effects of off-the-shelf leucine metabolite supplements HMB-FA, HMB-Ca, alfa-HICA, on resistance training-induced changes in body composition, performance and biochemical markers of muscle damage. The investigators' working hypothesis is that so long as subjects adhered to a diet containing adequate energy and dietary protein, there would be no differences between those receiving the leucine metabolites - HMB-FA, HMB-Ca and alfa-HICA - when compared to a placebo consuming group.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Leucine metabolites do not induce changes in phase angle, bioimpedance vector analysis patterns, and strength in resistance trained men.
Campa F, Matias CN, Teixeira FJ, Reis JF, et al · · 2021 · cited 10× · PMID 33337947 · DOI 10.1139/apnm-2020-0915 -
Association between Phase Angle from Bioelectric Impedance and Muscular Strength and Power in Physically Active Adults.
Fukuoka AH, de Oliveira NM, Matias CN, Teixeira FJ, et al · · 2022 · cited 7× · PMID 36138734 · DOI 10.3390/biology11091255
Verify or expand the search:
- PubMed search for NCT03511092
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Resistance Training
Currently open trials in the same condition.
- NCT06360536 — Remotely Delivered Resistance Training for Cardiometabolic Health Among Black Women · NA · recruiting
- NCT06765486 — Exercise-Induced Hypoalgesia Differences Between Upper and Lower Limbs Resistance Training Interventions · NA · recruiting
- NCT06679491 — Impact of Menstrual Cycle-Based Resistance Training on Neuromuscular Performance in Female Athletes · NA · recruiting
- NCT07347912 — Group-based Resistance Training for Adults With Down Syndrome · NA · active not recruiting
- NCT06536803 — Effects of High Load Strength Training With and Without Tissue Specific Planter Facia Stretching With Planter Fasciitis · NA · recruiting
Other Faculdade de Motricidade Humana trials
Trials by the same sponsor.
- NCT07079722 — More Health Less Diabetes · NA · recruiting
- NCT06919237 — Effects of Heart Rate Variability-guided Training vs Standard Aerobic Prescription on Cardiovagal Modulation and Cardior · NA · not yet recruiting
- NCT05090501 — The Effects of High Intensity Circuit Training in Nature Vs. Indoor on Exercise Performance, and Wellbeing · NA · completed
- NCT07105410 — Hypoalgesic Effects of Exercise and Training of Different Modalities · NA · completed
- NCT05380089 — Effects of Hydration Changes on Neuromuscular Function of Athletes · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03511092 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Faculdade de Motricidade Humana
- Last refreshed: 22 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03511092.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing